未登录

H

Helen W. Sullivan

us food & drug administration (fda)

H指数:20

被引数:1,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinicians' Reactions to Point-of-Care Advertising in Electronic Health Records

临床医生对电子健康记录中即时处方的广告的反应

Therapeutic Innovation & Regulatory Science

IF1.9

2026-07-010

PRE

Cancer Survivors' and Caregivers' Understanding of FDA Accelerated Approval Disclosures

癌症幸存者和护理人员对FDA加速批准披露文件的理解

JOURNAL OF CANCER EDUCATION

IF1.3

2025-11-010

PRE

Content Analysis of Promotional Materials for Prescription Drugs Authorized Under Emergency Use Authorization

处方药紧急使用授权下促销材料的内容分析

IF3.8

2025-09-250

PRE

Consumer Engagement With Risk Information on Prescription Drug Social Media Pages: Findings From In-Depth Interviews

消费者与处方药社交媒体页面风险信息的互动：深度访谈结果

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2025-03-250

OA

Communicating therapeutic indication information in direct-to-consumer television ads for prescription cancer drugs: Exploring the effect of dual-modality presentations

向消费者传递处方抗癌药物广告中的治疗适应症信息：探讨双模态呈现方式的影响

PATIENT EDUCATION AND COUNSELING

IF3.1

2025-03-010

PRE

Laypersons' understanding of statistical concepts commonly used in prescription drug promotion: A review of the research literature

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2024-12-010

PRE

Public and health care provider attitudes, understanding, and behaviors regarding emergency use authorizations: a scoping literature review

BMC PUBLIC HEALTH

IF3.6

2024-10-110

OAAI

A scoping review of empirical research on prescription drug promotion

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2023-06-011

PRE

Character-space-limited online prescription drug communications: Four experimental studies

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-12-010

OAAI

Physicians' use of and preferences for FDA-approved prescribing information

医师对FDA批准的处方信息的使用和偏好

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-06-014

OAAI

Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2021-05-0112

OAAI

Assessing the Inclusion of Foil Items in a Scale to Measure Recognition of Health Messages

COMMUNICATION METHODS AND MEASURES

IF3.7

2020-05-311

OAAI

The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements

MEDICAL DECISION MAKING

IF2.3

2019-10-045

OAAI

Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2019-04-239

OAAI

Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review

HEALTH COMMUNICATION

IF2.7

2019-04-1128

OAAI

Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2018-01-239

OA

Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis

HEALTH COMMUNICATION

IF2.7

2017-11-1018

OA

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis

JOURNAL OF MEDICAL INTERNET RESEARCH

IF6

2017-07-048

OAAI

Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2017-01-277

OAAI

Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2016-11-029

OAAI